Should Patients who have Persistent Severe Symptoms Receive a Left Ventricular Assist Device or Cardiac Resynchronization Therapy as the Next Step?

Heart Failure Clinics

Volumn 3, Issue 3, 2007, Pages 267-273

  Cleland, John ^a   Tageldien, Ahmed ^a   Khaleva, Olga ^a   Hobson, Neil ^a   Clark, Andrew L ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC DYSSYNCHRONY; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR EQUIPMENT; CLINICAL PRACTICE; DEFIBRILLATOR; ECHOCARDIOGRAPHY; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE; HUMAN; KNOWLEDGE; REVIEW; SYMPTOM;

CARDIAC OUTPUT, LOW; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; HEART-ASSIST DEVICES; HUMANS; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 34548127070     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2007.05.005     Document Type: Review

References (21)

1. Cleland J.G.F., Swedberg K., Follath F., et al., For the study group on diagnosis of the working group on heart failure of the European society of cardiology. The EuroHeart failure survey programme: survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24 (2003) 422-463
2. Cleland J.G.F., Cohen-Solal A., Cosin-Aguilar J., et al., For the IMPROVEMENT of Heart Failure Programme Committees and Investigators and the Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. An International Survey of the Management of Heart Failure in Primary Care. The IMPROVEMENT of Heart Failure Programme. Lancet 360 (2002) 1631-1639
3. Cleland J.G.F., Daubert J.-C., Erdmann E., et al., For the Cardiac Resynchronisation - Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
4. Khand A.U., Rankin A.C., Martin W., et al. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure. J Am Coll Cardiol 42 (2003) 1944-1951
5. Ponikowski P., Anker S., Szachniewicz J., et al. Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 49 (2007) 753-762
6. Cleland J.G.F., Ghosh J., Freemantle N., et al. Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-LIPIDS and cardiac resynchronisation therapy in heart failure. Eur J Heart Fail 6 (2004) 501-508
7. Cleland J.G.F., Findlay I., Jafri S., et al. The Warfarin/Aspirin Study in Heart Failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J 148 (2004) 157-164
8. Cleland J.G.F., Freemantle N., Ball S.G., et al. The heart failure revascularization trial (HEART): rationale design and methodology. Eur J Heart Fail 5 3 (2003) 295-303
9. Buckberg G.D. Questions and answers about the STICH trial: a different perspective. J Thorac Cardiovasc Surg 130 (2005) 245-249
10. Cleland J.G.F., Alamgir F., Nikitin N., et al. What is the optimal medical management of ischaemic heart failure?. Prog Cardiovasc Dis 43 5 (2001) 433-455
11. Schachinger V., Erbs S., Elsasser A., et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 27 (2006) 2775-2783
12. Bartunek J., Dimmeler S., Drexler H., et al. The consensus of the task force of the European society of cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur Heart J 27 (2006) 1338-1340
13. Cleland J.G.F., Nasir M., and Tageldien A. Cardiac resynchronization therapy or atriobiventricular pacing-what should it be called?. Nat Clin Pract Cardiovasc Med 4 2 (2007) 90-101
14. Cleland J.G.F., Daubert J.-C., Erdmann E., et al., On behalf of the CARE-HF study investigators. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the Cardiac Resynchronization - Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 27 16 (2006) 1928-1932
15. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
16. Cleland J.G.F., Daubert J.C., Erdmann E., et al. Design and methodology of the CARE-HF trial. A randomised trial of cardiac resynchronisation in patients with heart failure and ventricular dyssynchrony. Eur J Heart Fail 3 (2001) 481-489
17. Khan N.K., Goode K.M., Cleland J.G.F., et al., For the EuroHeart failure survey investigators. Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge. Eur J Heart Fail 9 (2007) 491-501
18. Freemantle N., Tharmanathan P., Calvert M.J., et al. Cardiac resynchronization for patients with heart failure due to left ventricular systolic dysfunction a systematic review and meta-analysis. Eur J Heart Fail 8 (2006) 433-440
19. Moss A.J., Brown M.W., Cannom D.S., et al. Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol. Ann Noninvasive Electrocardiol 10 (2005) 34-43
20. Yao G., Freemantle N., Calvert M., et al. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J 28 1 (2007) 42-51
21. Cleland J.G.F. The Trans-European Network - Home-Care Management System (TEN-HMS) Study: an investigation of the effect of telemedicine on outcomes in Europe. Dis Manag Health Out 14 Suppl 1 (2006) 23-28